Trial ID or NCT#

NCT03509350

Status

RECRUITING

Purpose

The VItamin C, Thiamine And Steroids in Sepsis (VICTAS) Study is a double-blind, placebo-controlled, adaptive randomized clinical trial designed to investigate the efficacy of the combined use of vitamin C, thiamine and corticosteroids versus indistinguishable placebos for patients with sepsis. The objective of this study is to demonstrate the efficacy of combination therapy using vitamin C, thiamine and corticosteroids in reducing mortality and improving organ function in critically ill patients with sepsis.

Official Title

A Multi-center, Randomized, Placebo-controlled, Double-blind, Adaptive Clinical Trial of Vitamin C, Thiamine and Steroids as Combination Therapy in Patients With Sepsis.

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

James Quinn
Emergency medicine doctor, Pediatric emergency medicine doctor
Professor of Emergency Medicine and, by courtesy, of Health Research and Policy at the Stanford University Medical Center
Jennifer Wilson
Emergency medicine doctor
Clinical Assistant Professor, Emergency Medicine

Contact us to find out if this trial is right for you.

CONTACT

Rosen Mann
(408) 460-5885